JPY 459.0
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.77 Billion | 965 Million | -309 Million | 8.79 Billion | 3.86 Billion | 2.63 Billion |
Net Income | -477 Million | 79 Million | 1.43 Billion | 4.43 Billion | 389 Million | 346 Million |
Depreciation & Amortization | 2.12 Billion | 1.99 Billion | 1.89 Billion | 1.81 Billion | 1.9 Billion | 1.89 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -750 Million | -1.47 Billion | -1.87 Billion | 1.67 Billion | 549 Million | -307 Million |
Other non-cash items | 6.19 Billion | 371 Million | -1.76 Billion | 867 Million | 1.01 Billion | 705 Million |
Investing Cash Flow | -2.11 Billion | -3.2 Billion | -2.01 Billion | -1.22 Billion | -1.35 Billion | -2.05 Billion |
Investments in PPE | -2.36 Billion | -3.12 Billion | -1.98 Billion | -1.05 Billion | -1.76 Billion | -2.06 Billion |
Acquisitions | 437 Million | - | 32 Million | -286 Million | -126 Million | - |
Investment purchases | -169 Million | - | -61 Million | -27 Million | -2 Million | -24 Million |
Sales/Maturities of investments | 35 Million | - | 18 Million | 1 Million | 571 Million | - |
Other Investing Activities | -59 Million | -76 Million | -21 Million | 137 Million | -33 Million | 42 Million |
Financing Cash Flow | 165 Million | 1.67 Billion | 1.03 Billion | -6.81 Billion | -1.96 Billion | -586 Million |
Debt repayment | -627 Million | -6.08 Billion | -6.22 Billion | -6.3 Billion | -6.48 Billion | -8 Billion |
Dividends payments | -458 Million | -458 Million | -458 Million | -343 Million | -343 Million | -344 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1 Million | 8.21 Billion | 7.72 Billion | -158 Million | 4.85 Billion | 7.76 Billion |
Accounts receivables | -86 Million | 11 Million | -12 Million | 118 Million | -686 Million | -51 Million |
Accounts payables | -708 Million | -769 Million | -647 Million | 165 Million | 121 Million | -647 Million |
Inventory | -266 Million | -475 Million | 123 Million | 1.03 Billion | 790 Million | 456 Million |
Other working capital | 310 Million | -245 Million | -1.33 Billion | 357 Million | 324 Million | -65 Million |
Cash at beginning of period | 2.57 Billion | 3.13 Billion | 4.2 Billion | 3.44 Billion | 2.9 Billion | 2.9 Billion |
Cash at end of period | 2.4 Billion | 2.57 Billion | 3.13 Billion | 4.2 Billion | 3.44 Billion | 2.9 Billion |
Capital Expenditure | -2.36 Billion | -3.12 Billion | -1.98 Billion | -1.05 Billion | -1.76 Billion | -2.06 Billion |
Effect of forex changes on cash | 730 Million | - | 221 Million | - | -1 Million | - |
Net cash flow / Change in cash | -174 Million | -562 Million | -1.06 Billion | 758 Million | 544 Million | -2 Million |
Free Cash Flow | -583 Million | -2.15 Billion | -2.29 Billion | 7.74 Billion | 2.1 Billion | 566 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 19 Million | -477 Million | -391 Million | -247 Million | 111 Million | 50 Million |
Depreciation & Amortization | - | 2.12 Billion | - | 539 Million | 524 Million | 496 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -750 Million | - | - | - | - |
Other non-cash items | -19 Million | 6.19 Billion | 391 Million | 247 Million | -111 Million | -50 Million |
Investing Cash Flow | - | -2.11 Billion | - | - | - | - |
Investments in PPE | - | -2.36 Billion | - | - | - | - |
Acquisitions | - | 437 Million | - | - | - | - |
Investment purchases | - | -169 Million | - | - | - | - |
Sales/Maturities of investments | - | 35 Million | - | - | - | - |
Other Investing Activities | - | -59 Million | - | - | - | - |
Financing Cash Flow | - | 165 Million | - | - | - | - |
Debt repayment | - | -627 Million | - | - | - | - |
Dividends payments | - | -458 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1 Million | - | - | - | - |
Accounts receivables | - | -86 Million | - | - | - | - |
Accounts payables | - | -708 Million | - | - | - | - |
Inventory | - | -266 Million | - | - | - | - |
Other working capital | - | 310 Million | - | - | - | - |
Cash at beginning of period | - | 2.57 Billion | - | 3.24 Billion | 5.94 Billion | 2.57 Billion |
Cash at end of period | - | 2.4 Billion | - | 4.43 Billion | 3.24 Billion | 5.94 Billion |
Capital Expenditure | - | -2.36 Billion | - | - | - | - |
Effect of forex changes on cash | - | 730 Million | - | - | - | - |
Net cash flow / Change in cash | - | -174 Million | - | 1.19 Billion | -2.69 Billion | 3.36 Billion |
Free Cash Flow | - | -583 Million | - | 1.07 Billion | 1.04 Billion | 992 Million |
AVADHSUGAR
ASYS
6566
KAY
EPSIL
TRC